정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1794 | Recruiting | COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers | Chronic Stable Illness | Drug: casirivimab+imdevimab Biological: Moderna mRNA-1273 vaccine |
Phase 2 | Regeneron Pharmaceuticals | INDUSTRY | 286 | All | 18 Years ~ 90 Years | Regeneron Research Site, Little Rock, Arkansas, United States Regeneron Research Site, Rogers, Arkansas, United States Regeneron Research Site, Hialeah, Florida, United States Regeneron Research Site, Miami, Florida, United States Regeneron Research Site, Orlando, Florida, United States Regeneron Research Site, Dayton, Ohio, United States |
| 1793 | Not yet recruiting | COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease | SARS-CoV-2 | Drug: REGN14256 Drug: imdevimab Drug: casirivimab + imdevimab Drug: Placebo |
Phase 2 | Regeneron Pharmaceuticals | INDUSTRY | 1359 | All | 12 Years ~ 65 Years | |
| 1792 | Not yet recruiting | COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines | Covid19 | Biological: hAd5-S-Fusion+N-ETSD vaccine | Phase 2 | ImmunityBio, Inc. | INDUSTRY | 540 | All | 18 Years ~ 80 Years | Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States |
| 1791 | Not yet recruiting | COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines | Covid19 | Biological: hAd5-S-Fusion+N-ETSD vaccine | Phase 2 | ImmunityBio, Inc. | INDUSTRY | 540 | All | 18 Years ~ 80 Years | Chan Soon-Shiong Institute for Medicine, El Segundo, California, United States |
| 1790 | Not yet recruiting | COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor EP-7041 in ICU Patients | Covid19 | Drug: EP-7041 Injection | Phase 2 | eXIthera Pharmaceuticals | INDUSTRY | 90 | All | 18 Years | |
| 1789 | Recruiting | COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis | Covid19 | Drug: Apixaban 2.5 MG Drug: Placebo |
Phase 3 | Thomas L. Ortel, National Heart, Lung, and Blood Institute (NHLBI) | OTHER | 5320 | All | 18 Years | Valleywise Health Medical Center, Phoenix, Arizona, United States Dignity Health-St Josephs, Phoenix, Arizona, United States Central Arkansas Veterans Health Care System, Little Rock, Arkansas, United States University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States National Institute of Clinical Research, Inc. Healthcare System 2000, Garden Grove, California, United States Emanate Health (Reddy Medical Center), Pomona, California, United States New Ananda Medical and Urgent Care, Inc., S. El Monte, California, United States UCSF at Zuckerberg San Francisco General Hospital, San Francisco, California, United States Mazur and Statner MD PC, Thousand Oaks, California, United States Torrance Medical Center, Torrance, California, United States Penrose Hospital, Colorado Springs, Colorado, United States St. Francis Medical Center, Colorado Springs, Colorado, United States Centura Health Porter Adventist Hospital, Denver, Colorado, United States Saint Anthony Hospital, Lakewood, Colorado, United States St. Anthony North Health Campus, Westminster, Colorado, United States Baycare Hospital, Clearwater, Florida, United States Florida Heart Center, Fort Pierce, Florida, United States University of Florida, Gainesville, Florida, United States Mount Sinai Medical Center, Miami Beach, Florida, United States Tallahassee Memorial HealthCare, Tallahassee, Florida, United States Triple O Research Institute, P.A., West Palm Beach, Florida, United States BayCare Hospital- Winter Haven, Winter Haven, Florida, United States Emory University, Atlanta, Georgia, United States Medical College of Georgia/Augusta University, Augusta, Georgia, United States Savannah Health Services, LLC DBA Memorial Health University Medical Center, Savannah, Georgia, United States Queens Medical Center, Honolulu, Hawaii, United States Hawaii Pacific Health, Honolulu, Hawaii, United States Snake River Research, PLLC, Idaho Falls, Idaho, United States University of Illinois at Chicago, Chicago, Illinois, United States Cook County Health, Chicago, Illinois, United States Rush University Medical Center, Chicago, Illinois, United States The University of Chicago Medicine, Chicago, Illinois, United States OSF Little Company of Mary, Evergreen Park, Illinois, United States Loyola University Medical Center, Maywood, Illinois, United States Indiana University Health Bloomington Hospital, Bloomington, Indiana, United States Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States Franciscan Health Michigan City, Michigan City, Indiana, United States Reid Physician Associates, Richmond, Indiana, United States Baptist Health Lexington, Lexington, Kentucky, United States University Medical Center New Orleans, New Orleans, Louisiana, United States Ochsner Clinic Foundation-Baton Rouge, New Orleans, Louisiana, United States Ochsner Clinic Foundation, New Orleans, Louisiana, United States Willis-Knighton Physician Network/Tri-State Medical Clinic, Shreveport, Louisiana, United States Maine Medical Center/Maine Medical Partners Adult Hospital Medicine, Portland, Maine, United States Pen Bay Medical Center, Rockport, Maine, United States Anne Arundel Medical Center, Annapolis, Maryland, United States Lifebridge (Sinai Hospital of Baltimore), Baltimore, Maryland, United States Adventist HealthCare Shady Grove Medical Center, Rockville, Maryland, United States Boston University, Boston, Massachusetts, United States Lahey Hospital and Medical Center, Burlington, Massachusetts, United States Baystate Medical center, Springfield, Massachusetts, United States Bay Regional Medical Center d/b/a/ McLaren Bay Region, Bay City, Michigan, United States Henry Ford Hospital, Detroit, Michigan, United States Western Michigan University, Kalamazoo, Michigan, United States MidMichigan Medical Center, Midland, Michigan, United States McLaren Macomb, Mount Clemens, Michigan, United States Minneapolis VA Health Care System, Minneapolis, Minnesota, United States Truman Medical Center, Kansas City, Missouri, United States Barnes-Jewish Hospital, Saint Louis, Missouri, United States Mercury Street Medical Group, Butte, Montana, United States CHI St Elizabeth Hospital, Lincoln, Nebraska, United States Renown Health, Reno, Nevada, United States AtlantiCare Regional Medical Center, Atlantic City, New Jersey, United States Newark Beth Israel Medical Center, Newark, New Jersey, United States Capital Health System, Inc., Trenton, New Jersey, United States Christus St. Vincent Regional Medical Center, Santa Fe, New Mexico, United States Montefiore Medical Center, Bronx, New York, United States NYU Langone Hospital-Brooklyn, Brooklyn, New York, United States Coney Island Hospital, Brooklyn, New York, United States Buffalo General Medical Center, Buffalo, New York, United States Mercy Hospital Buffalo, Buffalo, New York, United States Jamaica Hospital Medical Center, Jamaica, New York, United States New York University Langone Health, New York, New York, United States Stony Brook University Hospital, Stony Brook, New York, United States University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States Duke Medical Center, Durham, North Carolina, United States East Carolina University/Vidant Health, Greenville, North Carolina, United States Wake Med Hospital, Raleigh, North Carolina, United States Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States University of Cincinnati, Cincinnati, Ohio, United States Ohio State University, Columbus, Ohio, United States Kettering Medical Center, Kettering, Ohio, United States Oregon Health and Science University, Portland, Oregon, United States St. Luke's University Health Network, Easton, Pennsylvania, United States Temple University Hospital, Philadelphia, Pennsylvania, United States University of Pittsburgh, Pittsburgh, Pennsylvania, United States Tower Health Medical Group, West Reading, Pennsylvania, United States Rhode Island Hospital, Providence, Rhode Island, United States The Miriam Hospital, Providence, Rhode Island, United States Monument Health Clinical Research, Rapid City, South Dakota, United States Christus St. Elizabeth Hospital, Beaumont, Texas, United States Baylor Scott and White Medical Center- College Station, College Station, Texas, United States University of Texas Southwestern Medical Center, Dallas, Texas, United States UTHouston, Houston, Texas, United States Baylor Scott and White-Round Rock, Round Rock, Texas, United States Baylor Scott and White-Temple, Temple, Texas, United States The Woodlands Center For Respiratory & Sleep Research, The Woodlands, Texas, United States CHRISTUS Trinity Clinic Pulmonary Medicine, Tyler, Texas, United States The University of Texas Health Science Center at Tyler, Tyler, Texas, United States UT Health East Texas (Tyler), Tyler, Texas, United States UT Rio Grande Valley, Weslaco, Texas, United States MultiCare Institute for Research & Innovation, Puyallup, Washington, United States UW Medicine Valley Medical Center, Renton, Washington, United States Virginia Mason Medical Center, Seattle, Washington, United States CAMC Clinical Trials Center, Charleston, West Virginia, United States West Virginia University Hospital, Morgantown, West Virginia, United States Blood Center of Wisconsin, Milwaukee, Wisconsin, United States |
| 1788 | Completed | COVID-19 Treatment in South Africa | COVID-19 | Other: Standard of care (Paracetamol) Drug: Artesunate-amodiaquine Drug: Pyronaridine-artesunate Drug: Favipiravir plus Nitazoxanide Drug: Sofosbuvir/daclatasvir |
Phase 2 | Shin Poong Pharmaceutical Co. Ltd., Medicines for Malaria Venture | INDUSTRY | 192 | All | 18 Years ~ 65 Years | Ezintsha, Wits Reproductive Health & HIV Institute University of the Witwatersrand, Johannesburg, South Africa |
